Ten-year follow-up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa - Hauser, Robert A.; Rascol, Olivier; Korczyn, Amos D.; Jon Stoessl, A.; Watts, Ray L.; Poewe, Werner; De Deyn, Peter P.; Lang, Anthony E. (Movement disorders, 2007)
Keywords: Aged; Amantadine - adverse effects; Amantadine - therapeutic use; Antiparkinson Agents - adverse effects; Antiparkinson Agents - therapeutic use; Biological and medical sciences; Disability Evaluation; Disease Progression; dopamine agonist; Double-Blind Method; dyskinesia; Female; Follow-Up Studies; Humans; Indoles - adverse effects; Indoles - therapeutic use; levodopa; Levodopa - adverse effects; Levodopa - therapeutic use; Male; Medical sciences; Middle Aged; motor complications; Neurology; Parkinson Disease - drug therapy; Parkinson Disease - physiopathology; Parkinson's disease; ropinirole; treatment; Treatment Outcome; wearing off; Human; Nervous system diseases; Parkinson's disease; Parkinson disease; wearing off; motor complications; Involuntary movement; Cerebral disorder; Ropinirole; Treatment; Central nervous system disease; do pamine agonist; Complication; Degenerative disease; Levodopa; Neurological disorder; Extrapyramidal syndrome; Dyskinesia